Crescent Grove Advisors, LLC Aim Immuno Tech Inc. Transaction History
Crescent Grove Advisors, LLC
- $910 Million
- Q1 2025
A detailed history of Crescent Grove Advisors, LLC transactions in Aim Immuno Tech Inc. stock. As of the latest transaction made, Crescent Grove Advisors, LLC holds 45,390 shares of AIM stock, worth $2,723. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45,390Holding current value
$2,723% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AIM
# of Institutions
39Shares Held
4.69MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA1.99MShares$119,3220.0% of portfolio
-
Black Rock Inc. New York, NY698KShares$41,8960.0% of portfolio
-
Geode Capital Management, LLC Boston, MA464KShares$27,8400.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il359KShares$21,5390.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny260KShares$15,6280.0% of portfolio
About AIM ImmunoTech Inc.
- Ticker AIM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,049,300
- Market Cap $2.88M
- Description
- AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...